These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9698051)

  • 41. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of dopaminergic agents on carrageenan hyperalgesia in rats.
    Gao X; Zhang Y; Wu G
    Eur J Pharmacol; 2000 Oct; 406(1):53-8. PubMed ID: 11011033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dopamine autoreceptor agonist, (+/-)-trans-1,3,4,4a5,10b-hexahydro-4-propyl-2H [1]benzopyrano [3,4-b] pyridin-9-ol hydrochloride (CGS 15855A), modulates striatal dopamine metabolism and prolactin release.
    Iyengar S; Hausler A; Kim HS; Marien M; Altar CA; Wood PL
    Neuropharmacology; 1989 Jan; 28(1):27-31. PubMed ID: 2522597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction between LSD and dopamine D2/3 binding sites in pig brain.
    Minuzzi L; Nomikos GG; Wade MR; Jensen SB; Olsen AK; Cumming P
    Synapse; 2005 Jun; 56(4):198-204. PubMed ID: 15803496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
    Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
    Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs.
    Kilts JD; Connery HS; Arrington EG; Lewis MM; Lawler CP; Oxford GS; O'Malley KL; Todd RD; Blake BL; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1179-89. PubMed ID: 12023553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors.
    Bockaert J; Premont J; Glowinski J; Thierry AM; Tassin JP
    Brain Res; 1976 May; 107(2):301-15. PubMed ID: 1268730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
    Ohta K; Kuno S; Mizuta I; Fujinami A; Matsui H; Ohta M
    Life Sci; 2003 Jun; 73(5):617-26. PubMed ID: 12770616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats.
    Moro M; Inada Y; Miyata H; Komatsu H; Kojima M; Tsujii H
    Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):651-8. PubMed ID: 11473532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine inhibition of proopiomelanocortin gene expression in the intermediate lobe of the pituitary. Interactions with corticotropin-releasing factor and the beta-adrenergic receptors and the adenylate cyclase system.
    Loeffler JP; Demeneix BA; Kley NA; Höllt V
    Neuroendocrinology; 1988 Feb; 47(2):95-101. PubMed ID: 2963967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
    Gruszka A; Ren SG; Dong J; Culler MD; Melmed S
    Endocrinology; 2007 Dec; 148(12):6107-14. PubMed ID: 17656461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of coupling between D2 dopamine receptors and calcium channels in lactotrophs from cycling female rats.
    Rendt J; Oxford GS
    Endocrinology; 1994 Aug; 135(2):501-8. PubMed ID: 8033799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
    Meltzer HY; Simonovic M; Gudelsky GA
    Eur J Pharmacol; 1983 Aug; 92(1-2):83-9. PubMed ID: 6628538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of selective activation of dopamine D2 and D3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons.
    Durham RA; Eaton MJ; Moore KE; Lookingland KJ
    Eur J Pharmacol; 1997 Sep; 335(1):37-42. PubMed ID: 9371544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opposing roles for dopamine D1 and D2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons.
    Durham RA; Johnson JD; Eaton MJ; Moore KE; Lookingland KJ
    Eur J Pharmacol; 1998 Aug; 355(2-3):141-7. PubMed ID: 9760028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
    Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2007 Dec; 195(2):213-22. PubMed ID: 17668188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.